BioAtla BCAB
OTC BCAB
$1.80 -0.01 (-0.55%)
At close: Nov 10, 2026 · 4:00 PM EST

BioAtla (BCAB) FCF Margin (2020 - 2026)

Updated

BioAtla's FCF Margin came in at -6.45% for Q2 2026.

Analysis

BioAtla (BCAB) FCF Margin (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, BioAtla reported FCF Margin of -276.26%, up 163.43 percentage points year-over-year; for FY2025, it was -2410.20%, down 1756.24 percentage points from FY2024.

  • FCF Margin carries a five-year change of +6196.79 percentage points (FY2020 to FY2025).
  • Going back by year, FCF Margin was -653.96% in FY2024 and -25255.20% in FY2021 (-16648.21 pp).
  • The Q2 2026 figure represents the highest quarterly FCF Margin in data going back to Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 33.69%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.03%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 41.97%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.51%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 52.85%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.25%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 57.81%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 28.96%
10 BioAtla 2.99 Mn -15.95 Mn - -6.45%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.45%
Dec 31, 2025 -395.75%
Sep 30, 2024 -46.65%
Jun 30, 2024 -2,132.56%
Jun 30, 2021 -5,512.00%
Sep 30, 2020 -10,380.67%
Jun 30, 2020 -1,641.05%
Mar 31, 2020 -4,307.87%
API Access

BioAtla FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=BCAB&period=max&api_key=YOUR_API_KEY